Toward a New, Open Source Pharmaceutical Industry
|
CONFERENCE PURPOSE
Launch concrete initiatives to discover, develop, and commercialize medicines for the most pressing needs in our society through the use of open and inclusive research models. CONFERENCE OBJECTIVES Forge: The first-ever global conference on open source pharma. Many of the players have never met. Create ties, form community, and forge alliances. Learn: What does open source pharma mean? How does it relate to current, alternative pharma approaches? What is happening in the open source pharma field, and what is its applicability/potential at each stage of the pipeline? Act: Explore and develop concrete projects and paths forward:
|
PARTICIPANTS
Arpana Agarwal Urmi Bajpai – Delhi University Manica Balasegaram – Médecins Sans Frontières Jörg Bentzien – Boehringer-Ingelheim Pharmaceuticals Samir Brahmachari – Open Source Drug Discovery Sarah Dennis – McGill University Robert Don – Drugs for Neglected Diseases Initiative UC Jaleel – Open Source Drug Discovery Peter Kolb – University of Marburg John McKew – National Institutes of Health Jaykumar Menon – McGill University Bernard Munos – InnoThink and FasterCures Ganesh Neelam – Sir Ratan Tata Trust Sherwood Neiss – Crowdfund Capital Advisors Piero Olliaro – World Health Organization Melinda Richter – Janssen Labs/Johnson & Johnson Tomasz Sablinski – Transparency Life Sciences Zakir Thomas - Open innovation expert Matthew Todd – University of Sydney and Open Source Malaria Els Torreele – Open Society Foundations Dimitrios Tzalis - European Lead Federation John Wilbanks – Sage Bionetworks |
